rejuvant life tabs

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...

Latest news

Longevity supplements report: JUVICELL profile

Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement. Over the coming weeks, we will be bringing...

New perspective in gerontology: epigenetic rejuvenation

Can biological age be set back by "making the clock tick backwards"? Scientists suggest that a partial phenotypic rejuvenation can be gained. Since the discovery...

Gerostate Alpha opens crowdfunded capital raise

Buck Institute-founded start-up Gerostate Alpha seeks to crowdfund its biotech platform. When Y Combinator so likes your ideas, it gives you $1 million to start...

BioAge licenses Amgen drug to treat muscle aging

Exclusive deal to develop and commercialise Amgen’s Phase 1 APJ agonist, after BioAge platform identifies its potential in promoting longevity and reducing symptoms of...

Can leucine turbo-charge longevity supplements and drugs?

Our exclusive interview with NuSirt’s founder explores how combining the sirtuin-activating amino acid has the potential to enhance the effect of longevity supplements and...
Supps report ad middle

Diagnostics

New perspective in gerontology: epigenetic rejuvenation

Can biological age be set back by "making the clock tick backwards"? Scientists suggest that a partial phenotypic rejuvenation can be gained. Since the discovery...

First non-invasive biomarker to track and verify senolytics

Researchers at The Buck Institute develop a biomarker test for senolytics, paving the way for senotherapeutic treatments. Buck Institute researchers have discovered and are developing...

Bats’ contribution to DNA methylation research

New research into DNA methylation to accurately predict maximum lifespan and support longevity R&D. The study of reversible DNA modifications, known as epigenetics, has played...
Rejuvant

Biotech

BioAge licenses Amgen drug to treat muscle aging

Exclusive deal to develop and commercialise Amgen’s Phase 1...

Can leucine turbo-charge longevity supplements and drugs?

Our exclusive interview with NuSirt’s founder explores how combining...

Targeting mitochondria to beat hair loss and skin wrinkles

Yuva Biosciences gears up for human trials of cosmeceutical...

HitGen and BioAge progress drug discovery collaboration

Companies announce research progress in DNA-encoded library-based drug discovery...

Investment

Longevity supplements report: JUVICELL profile

Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement. Over the coming weeks, we will be bringing...

Gerostate Alpha opens crowdfunded capital raise

Buck Institute-founded start-up Gerostate Alpha seeks to crowdfund its biotech platform. When Y Combinator so likes your ideas, it gives you $1 million to start...

FOXO announces $10million investment to launch FOXO Life

FOXO Technologies Inc announces closing of $10 million investment to launch FOXO Life; continues commercialising epigenetic biomarker technology. FOXO Technologies Inc has announced that it...

Longevity supplements report: PDLH profile

The company behind Rejuvant, which partnered with the Buck Institute for Research on Aging on its calcium alpha-ketoglutarate longevity supplement. Over the coming weeks, we...

Longevity supplements report: Youth & Earth profile

Youth & Earth is keeping it natural, while slowing down aging. Over the coming weeks, we will be bringing you extracts of 11 company profiles...

Most popular articles

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...

Aubrey de Grey: Methuselarity by 2035 – and it’ll be free

Aubrey de Grey tells Longevity.Technology the revolution is coming, and everyone will be eligible. "I now think there is a 50% chance that we will...

Video

The Sheekey Science Show – Precision Medicine

What to expect for Precision medicine by 2030? All of us are unique. What may good for one persons health may be terrible for another's....

Biohacking our way back to physical events again

Tim Gray is the UK’s leading biohacking expert and founder/curator of the Health Optimisation Summit which takes place in London, 18-19 September: physical events...

The Sheekey Science Show – mitochondria and aging

The mitochondrial theory of aging. Mitochondria are the powerhouses of the cell involved in the generation of ATP, the cellular energy currency. However, during aging mitochondria...

Aubrey de Grey: Methuselarity by 2035 – and it’ll be free

Aubrey de Grey tells Longevity.Technology the revolution is coming, and everyone will be eligible. "I now think there is a 50% chance that we will...

Innovation

Renal fibrosis caused by telomere shortening – new research

CNIO researchers demonstrate that renal fibrosis is caused by telomere shortening, paving the way for future treatment. Researchers in the...

Successful free radical therapy? Targeting is key

SFRRI President-Elect Giovanni Mann reveals why targeting cellular antioxidant pathways needs to be as precise as possible – and...

Economy

Juvenescence appoints Chief Scientific Officer

Innovative biotech Juvenescence has announced it has appointed Dr Grazia Piizzi as its Chief Scientific Officer. Juvenescence Ltd, a life sciences company focused on modifying...

Jobs in longevity? Your new career starts here

Announcing our new 'jobs in longevity' system and international 'executive search' service. As many of us enter a long-weekend there'll be some downtime to consider...

The aging society: new challenges, new economy

From increased risk aversion to changed consumption patterns, CaixaBank Research economist highlights key issues presented by aging. The world is aging, and aging fast. The...

NIA announces funding for longevity clinical trials

New funding opportunity for longevity clinical trials from National Institute on Aging emphasises preventing aging and age-related disease. The NIA, which is part of the...
Supplement report
Supps report ad middle

Supplements

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Longevity supplements report: JUVICELL profile

Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement. Over the coming weeks, we will be bringing...

Can leucine turbo-charge longevity supplements and drugs?

Our exclusive interview with NuSirt’s founder explores how combining the sirtuin-activating amino acid has the potential to enhance the effect of longevity supplements and...

Longevity supplements report: PDLH profile

The company behind Rejuvant, which partnered with the Buck Institute for Research on Aging on its calcium alpha-ketoglutarate longevity supplement. Over the coming weeks, we...

Why turmeric can curry favour with your healthspan

The curcumin in turmeric has proven health benefits, from anti-inflammatory to cognitive; reaching for the spice jar isn't enough, but supplements could be. Turmeric is...

AI/Digital

Connected care start-up targets aging-in-place

PCL Health monitors key vitals at home, providing caregivers...

Gut bacteria start-up exits stealth with unique data

Wild Biotech plans to use database of more than...

AI first: novel drug target and novel molecule discovered

One step closer to senescence moonshot: Insilico claims industry...

Agetech

New investor offers funding to healthy aging innovators

A fifth investor has joined UK Research and Innovation (UKRI), providing matched funding for top small innovators to develop ideas for healthy aging. The new...

Connected care start-up targets aging-in-place

PCL Health monitors key vitals at home, providing caregivers with peace of mind and supporting aging-in-place. British start-up PCL Health (formerly Poonyah Care) is on...

AgeTech fund: focus on over-50s not millennials

Founding partner of 1843 Capital targets AgeTech investment opportunities with $13 million fund. Connecticut-based early stage investment firm 1843 Capital values diversity highly, and seeks...

Fall detection tech a focus for investors

EchoCare raising funds to target acute fall detection and other emergencies with privacy-sensitive, radar-based system. In the US-alone, for nonfatal falls, Medicare paid approximately $28.9...